Predictors of Recurrence for T3a RCC: A Recurring Conundrum

Diagnostics (Basel). 2020 Nov 21;10(11):983. doi: 10.3390/diagnostics10110983.

Abstract

Although the gold standard treatment for localized renal cell carcinoma (RCC) is radical nephrectomy (RN) or partial nephrectomy (PN), recurrence rates remain high at 7%, 26%, and 39% for T1, T2, and T3 staged disease, respectively [...].